Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 81
Filter
Add more filters

Complementary Medicines
Country/Region as subject
Publication year range
1.
Pain Med ; 18(3): 551-564, 2017 03 01.
Article in English | MEDLINE | ID: mdl-28395101

ABSTRACT

Objective: To systematically review the literature on the effectiveness of ear acupuncture (EA) for immediate pain relief. Data sources: AMED, CINAHL, Cochrane Reviews, Embase, PsycINFO, PubMed, Scopus Web of Science, from inception through March 2015. Study selection: English publications, randomized controlled trials on human subjects involving EA as a treatment for pain, with outcomes recorded within 48 hours. Data extraction and design: Two authors independently assessed trial eligibility, quality, results, and side effects, and extracted data; a third author checked final data. Effect size (d), mean difference (MD), and 95% confidence interval (CI) were calculated. The Physiotherapy Evidence Database (PEDro) scoring system was used to assess study quality. Meta-analysis was performed for two primary outcomes measures-pain intensity score and analgesic requirements. Results: Ten studies met inclusion criteria. Quality per PEDro scores: four excellent, four good, two fair. Based on their primary outcome measures, six studies showed EA being superior to its comparator, three showed no difference to comparators (which in all cases were analgesics), and one study showed significant pain decrease at the first time point and no significant decrease at the second. Meta-analysis was completed for the three studies that evaluated pain intensity as a primary outcome measure, and EA was superior to comparator (MD = -0.96, 95% CI = -1.82- -0.11), but the MD was small. Meta-analysis was completed for the six studies that evaluated analgesic requirements, and EA was superior (MD = -1.08, 95% CI = -1.78- -0.38]), again with a small MD. Six studies reported side effects; all were minor and transient. Conclusions: Ear acupuncture may be a promising modality to be used for pain reduction within 48 hours, with a low side effect profile. Rigorous research is needed to establish definitive evidence of a clinically significant difference from controls or from other pain treatments.


Subject(s)
Acupuncture, Ear/methods , Pain Management/methods , Humans , Randomized Controlled Trials as Topic
2.
Leukemia ; 31(6): 1269-1277, 2017 06.
Article in English | MEDLINE | ID: mdl-27840424

ABSTRACT

Chromosomal rearrangements of the mixed lineage leukemia (MLL/KMT2A) gene leading to oncogenic MLL-fusion proteins occur in ~10% of acute leukemias and are associated with poor clinical outcomes, emphasizing the need for new treatment modalities. Inhibition of the DOT1-like histone H3K79 methyltransferase (DOT1L) is a specific therapeutic approach for such leukemias that is currently being tested in clinical trials. However, in most MLL-rearranged leukemia models responses to DOT1L inhibitors are limited. Here, we performed deep-coverage short hairpin RNA sensitizer screens in DOT1L inhibitor-treated MLL-rearranged leukemia cell lines and discovered that targeting additional nodes of MLL complexes concomitantly with DOT1L inhibition bears great potential for superior therapeutic results. Most notably, combination of a DOT1L inhibitor with an inhibitor of the MLL-Menin interaction markedly enhanced induction of differentiation and cell killing in various MLL disease models including primary leukemia cells, while sparing normal hematopoiesis and leukemias without MLL rearrangements. Gene expression analysis on human and murine leukemic cells revealed that target genes of MLL-fusion proteins and MYC were suppressed more profoundly upon combination treatment. Our findings provide a strong rationale for a novel targeted combination therapy that is expected to improve therapeutic outcomes in patients with MLL-rearranged leukemia.


Subject(s)
Drug Resistance, Neoplasm/genetics , Enzyme Inhibitors/pharmacology , Gene Rearrangement , Histone-Lysine N-Methyltransferase/genetics , Leukemia/drug therapy , Methyltransferases/metabolism , Myeloid-Lymphoid Leukemia Protein/genetics , Proto-Oncogene Proteins/antagonists & inhibitors , RNA, Small Interfering/genetics , Animals , Apoptosis , Cell Proliferation , Drug Resistance, Neoplasm/drug effects , Female , Gene Expression Regulation, Leukemic , Histone-Lysine N-Methyltransferase/metabolism , Humans , Leukemia/genetics , Leukemia/pathology , Methyltransferases/genetics , Mice , Mice, Inbred C57BL , Mice, Nude , Myeloid-Lymphoid Leukemia Protein/metabolism , Tumor Cells, Cultured
3.
J Endocrinol Invest ; 37(8): 721-727, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24923901

ABSTRACT

PURPOSE: The immune response is altered according to hormonal and metabolic status. Obesity increases the inflammatory and fever response, whereas loss of gonadal steroid decreases behavioral response to immune stress. However, the immune systems of ovariectomized animals exhibiting obesity and gonadal steroid deficiency, particularly under septic conditions, have not been fully examined. In the present study, we evaluated the ovariectomy-induced changes of central and peripheral immune responses to life-threatening septic stimulus. METHODS AND RESULTS: Ovariectomized rats showed heavier body weight and lighter uterine weight when compared with gonadally intact rats. Fever response to septic dose of lipopolysaccharide (LPS) in ovariectomized rats was less evident when compared with that in gonadally intact rats. In addition, under LPS-injected septic conditions, hypothalamic gene levels of Interleukin-1ß (IL-1ß), Interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) and serum protein levels of IL-1ß and TNF-α in ovariectomized rats were lower than those in gonadally intact rats. On the other hand, IL-6 levels in visceral fat under septic conditions were higher in ovariectomized rats than in gonadally intact rats. CONCLUSIONS: These findings indicate that ovariectomy-induced site-specific changes in cytokine response under septic conditions. As hypothalamic, but not peripheral, pro-inflammatory cytokines are directly involved in the fever response, the attenuation of fever response observed in ovariectomized rats may be caused by a reduction in central cytokine responses.


Subject(s)
Aging , Cytokines/metabolism , Disease Models, Animal , Hypothalamus/immunology , Intra-Abdominal Fat/immunology , Obesity/immunology , Sepsis/immunology , Adiposity , Animals , Anorexia/etiology , Cytokines/blood , Cytokines/genetics , Female , Fever/etiology , Gene Expression Regulation, Developmental , Humans , Hypothalamus/metabolism , Intra-Abdominal Fat/metabolism , Intra-Abdominal Fat/pathology , Lipopolysaccharides , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neurons/immunology , Neurons/metabolism , Obesity/complications , Organ Size , Organ Specificity , Ovariectomy , Rats, Sprague-Dawley , Sepsis/complications , Sepsis/metabolism , Sepsis/physiopathology , Uterus/pathology
4.
Curr Med Chem ; 21(20): 2322-30, 2014.
Article in English | MEDLINE | ID: mdl-24438525

ABSTRACT

Anticancer drug research based on natural compounds enabled the discovery of many drugs currently used in cancer therapy. Here, we report the in vitro, in vivo and in silico anticancer and estrogen-like activity of Psidium guajava L. (guava) extracts and enriched mixture containing the meroterpenes guajadial, psidial A and psiguadial A and B. All samples were evaluated in vitro for anticancer activity against nine human cancer lines: K562 (leukemia), MCF7 (breast), NCI/ADR-RES (resistant ovarian cancer), NCI-H460 (lung), UACC-62 (melanoma), PC-3 (prostate), HT-29 (colon), OVCAR-3 (ovarian) and 786-0 (kidney). Psidium guajava's active compounds displayed similar physicochemical properties to estradiol and tamoxifen, as in silico molecular docking studies demonstrated that they fit into the estrogen receptors (ERs). The meroterpene-enriched fraction was also evaluated in vivo in a Solid Ehrlich murine breast adenocarcinoma model, and showed to be highly effective in inhibiting tumor growth, also demonstrating uterus increase in comparison to negative controls. The ability of guajadial, psidial A and psiguadials A and B to reduce tumor growth and stimulate uterus proliferation, as well as their in silico docking similarity to tamoxifen, suggest that these compounds may act as Selective Estrogen Receptors Modulators (SERMs), therefore holding significant potential for anticancer therapy.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Cell Proliferation/drug effects , Neoplasms/pathology , Plant Extracts/pharmacology , Psidium/chemistry , Selective Estrogen Receptor Modulators/pharmacology , Animals , Cell Line, Tumor , Computational Biology/methods , Estrogens , Female , Humans , Mice, Inbred BALB C , Neoplasms/metabolism , Plant Extracts/chemistry , Plant Leaves/chemistry , Xenograft Model Antitumor Assays
5.
Br J Surg ; 97(12): 1791-7, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20799286

ABSTRACT

BACKGROUND: This study investigated the influence of mechanical bowel preparation (MBP) on faecal microflora, using rRNA-targeted reverse transcription-quantitative polymerase chain reaction in patients undergoing colonic cancer resection. METHODS: Forty-two patients undergoing elective colonic surgery were randomized into MBP or no-MBP groups (21 in each group). The main outcome was the bacterial microflora and faecal organic acid content of faecal material obtained at operation. RESULTS: Clinical characteristics were similar in the two groups. Bowel content in the resected specimens did not differ significantly. The count of bacterial microflora, such as Bifidobacterium and total Lactobacillus, in both intraoperative faecal material and first material after surgery was significantly lower in the MBP group than the no-MBP group (P < 0·050). Levels of faecal organic acids, such as acetic acid, propionic acid and butyric acid, in intraoperative faecal material were significantly lower, and levels of lactic acid were significantly higher, in the MBP group than in the no-MBP group (P < 0·050). The succinic acid level was significantly higher after surgery than before operation in the MBP group (P = 0·008). CONCLUSION: Preoperative MBP caused an imbalance in the bowel microflora, suggesting that it offers no advantages in terms of enterobacterial microflora for patients undergoing colonic cancer resection. REGISTRATION NUMBER: UMIN000003153 (http://www.umin.ac.jp/ctr/index.htm).


Subject(s)
Cathartics/therapeutic use , Citric Acid/therapeutic use , Colonic Neoplasms/surgery , Feces/microbiology , Organometallic Compounds/therapeutic use , Preoperative Care/methods , Aged , Aged, 80 and over , Antibiotic Prophylaxis , Enema , Female , Humans , Male , Middle Aged , Recovery of Function , Reverse Transcriptase Polymerase Chain Reaction , Treatment Outcome
6.
J Physiol ; 588(Pt 5): 821-9, 2010 Mar 01.
Article in English | MEDLINE | ID: mdl-20083512

ABSTRACT

Recent studies have suggested that intrauterine undernutrition is closely associated with the pathogenesis of diseases after birth. Perinatal undernutrition is known to disturb the development of reproductive function and delay the onset of puberty in some species. Using a rat model, we determined the effects of prenatal undernutrition on the development of the hypothalamic kisspeptin system and evaluated whether the alteration of the kisspeptin system contributes to the delayed onset of puberty induced by prenatal undernutrition. We also evaluated the effects of prenatal undernutrition on the developmental changes in serum leptin levels because leptin was a putative positive regulator of the hypothalamic kisspeptin system. We compared the timing of vaginal opening (VO) and the developmental changes in body weight, hypothalamic Kiss1 mRNA levels, and serum leptin concentrations between offspring with prenatal undernutrition (UN offspring) and normal nutrition (NN offspring). After birth, the UN offspring showed rapid growth and had caught up to body weight of the NN offspring by postnatal day 12. After postnatal day 16, the UN offspring showed significantly lower Kiss1 mRNA levels than the NN offspring, despite their significantly higher serum leptin levels (at days 20 and 28). The timing of VO in the UN offspring was delayed compared with that in the NN offspring, and chronic central injection of kisspeptin normalized the timing of VO in the UN offspring. These results suggest that decreased hypothalamic kisspeptin action contributes to the delayed onset of puberty in prenatally undernourished female rats. Increased leptin resistance in the kisspeptin system might be involved in these alterations.


Subject(s)
Hypothalamus/embryology , Hypothalamus/metabolism , Malnutrition/embryology , Malnutrition/metabolism , Proteins/metabolism , Animals , Female , Hypothalamus/growth & development , Kisspeptins , Rats , Rats, Sprague-Dawley
7.
Neuroscience ; 166(1): 292-304, 2010 Mar 10.
Article in English | MEDLINE | ID: mdl-20006972

ABSTRACT

In inflamed tissues, extracellular pH decreases and acidosis is an important source of pain. Histamine is released from mast cells under inflammatory conditions and evokes the pain sensation in vivo, but the cellular mechanism of histamine-induced pain has not been well understood. In the present study, we examined the effects of histamine on [Ca(2+)](i) and membrane potential responses to acid in isolated mouse dorsal root ganglion (DRG) neurons. In capsaicin-sensitive DRG neurons from wild-type mice, acid (>pH 5.0) evoked [Ca(2+)](i) increases, but not in DRG neurons from transient receptor potential V1 (TRPV1) (-/-) mice. Regardless of isolectin GS-IB4 (IB4)-staining, histamine potentiated [Ca(2+)](i) responses to acid (>or=pH 6.0) that were mediated by TRPV1 activation. Histamine increased membrane depolarization induced by acid and evoked spike discharges. RT-PCR indicated the expression of all four histamine receptors (H1R, H2R, H3R, H4R) in mouse DRG. The potentiating effect of histamine was mimicked by an H1R agonist, but not H2R-H4R agonists and was inhibited only by an H1R antagonist. Histamine failed to potentiate the [Ca(2+)](i) response to acid in the presence of inhibitors for phospholipase C (PLC) and protein kinase C (PKC). A lipoxygenase inhibitor and protein kinase A inhibitor did not affect the potentiating effects of histamine. Carrageenan and complete Freund's adjuvant produced inflammatory hyperalgesia, but these inflammatory conditions did not change the potentiating effects of histamine in DRG neurons. The present results suggest that histamine sensitizes acid-induced responses through TRPV1 activation via H1R coupled with PLC/PKC pathways, the action of which may be involved in the generation of inflammatory pain.


Subject(s)
Ganglia, Spinal/metabolism , Histamine/pharmacology , Nociceptors/metabolism , Pain/metabolism , Sensory Receptor Cells/metabolism , TRPV Cation Channels/drug effects , Acids/pharmacology , Action Potentials/drug effects , Action Potentials/physiology , Animals , Calcium Signaling/drug effects , Calcium Signaling/physiology , Enzyme Inhibitors/pharmacology , Ganglia, Spinal/cytology , Histamine/metabolism , Histamine Agonists/pharmacology , Histamine H1 Antagonists/pharmacology , Inflammation Mediators/pharmacology , Male , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Pain/genetics , Pain/physiopathology , Patch-Clamp Techniques , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/metabolism , Sensory Receptor Cells/cytology , TRPV Cation Channels/genetics , Type C Phospholipases/antagonists & inhibitors , Type C Phospholipases/metabolism
8.
J Endocrinol Invest ; 31(7): 656-9, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18787387

ABSTRACT

Kisspeptin and its corresponding receptor, the G protein-coupled receptor 54, play an important role in reproductive systems. It has been suggested that reproductive disorders in metabolically disrupted animals are caused by the alteration of hypothalamic KiSS-1 systems. Immune/inflammatory challenge is also known to disrupt reproductive function. However, the effects of immune/inflammatory challenge on KiSS-1 systems have not been investigated. In this study, we showed that lipopolysaccharide (LPS) injection decreased hypothalamic KiSS-1 mRNA expression as well as plasma LH levels in ovariectomized rats. Indomethacin completely blocked the suppressive effects of LPS on LH secretion and KiSS-1 mRNA level. Furthermore, we showed that i.v. injection of kisspeptin increased plasma LH levels in LPS-administrated rats to the same degree as in saline-injected rats. These results suggest that KiSS-1 systems are sensitive to immune/inflammatory challenge conditions and transmit these signals into the central reproductive system.


Subject(s)
Inflammation/metabolism , Luteinizing Hormone/metabolism , Proteins/metabolism , Stress, Physiological , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Female , Gonadotropin-Releasing Hormone/genetics , Gonadotropin-Releasing Hormone/metabolism , Hypothalamus/drug effects , Hypothalamus/metabolism , Indomethacin/pharmacology , Kisspeptins , Lipopolysaccharides/immunology , Luteinizing Hormone/blood , Proteins/genetics , Rats , Rats, Wistar , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Receptors, Kisspeptin-1
9.
Vet Res Commun ; 31(1): 83-92, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17180448

ABSTRACT

Concentrations of bovine carbonic anhydrase isozyme VI (CA-IV) in bovine serum, saliva, normal milk, colostrum, submandibular gland, liver, and mammary gland were determined. CA-VI was purified from bovine saliva and an antibody to CA-VI was generated. The concentrations of CA-VI in the saliva (7.8 +/- 7.9 microg/ml), serum (2.1+/- 5.7 ng/ml), milk (7.9 +/- 12.1 ng/ml), submandibular gland (284.7 microg/g protein), liver (921.0 +/- 180.7 ng/g protein) and mammary gland (399.6 +/- 191.2 ng/g protein) were determined by ELISA. No seasonal change in CA-VI levels was observed in normal milk. The concentration of CA-VI in colostrum (day 1 post partum) was 119 ng/ml and decreased rapidly by 1 month following birth. Mammary gland contained much smaller amounts than the submandibular gland. CA-VI mRNA was detected in the liver and mammary gland of cow by RT-PCR. The ELISA used in this study proved to be a precise and sensitive method for determining CA-VI concentrations in saliva, serum, milk and tissue specimens from cows. The ELISA may enable the study of changes in CA-VI associated with hereditary or metabolic disorders of the salivary gland, mammary gland and liver using small samples of saliva, serum or milk.


Subject(s)
Carbonic Anhydrases/analysis , Cattle/metabolism , Milk/enzymology , Saliva/enzymology , Animals , Carbonic Anhydrases/blood , Carbonic Anhydrases/genetics , Colostrum/enzymology , Enzyme-Linked Immunosorbent Assay/veterinary , Female , Liver/enzymology , Mammary Glands, Animal/enzymology , RNA/chemistry , RNA/genetics , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Submandibular Gland/enzymology
10.
Br J Nutr ; 90(6): 1031-8, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14641962

ABSTRACT

The prevention of arterial thrombotic diseases has a high priority in developed countries. An inappropriate diet may be an important risk factor for thrombotic events. The daily intake of an anti-thrombotic diet may offer a convenient and effective way of prevention. The aim of the present study was to test tomato extracts for anti-thrombotic effects and to identify those varieties that have such an effect. A shear-induced platelet-function test (haemostatometry) was used to test anti-thrombotic potential in vitro. Extracts from those tomato varieties that showed a significant anti-thrombotic activity in vitro were further assessed in vivo, using a laser-induced thrombosis test in mice. One tomato variety (KG99-4) showed significant anti-thrombotic activity both in vitro and in vivo. KG99-4 inhibited not only platelet-rich thrombus formation but also had a thrombolytic effect. It is concluded that haemostatometry can detect and classify the anti-thrombotic potential of fruits and vegetables and offers a simple way of screening for such effects.


Subject(s)
Diet , Solanum lycopersicum , Thrombosis/prevention & control , Animals , Blood Coagulation/drug effects , Fibrinolytic Agents/pharmacology , Hot Temperature , Lasers , Solanum lycopersicum/classification , Male , Mice , Mice, Inbred C57BL , Plant Extracts/pharmacology , Platelet Aggregation/drug effects , Platelet Function Tests/methods , Rats , Rats, Wistar , Species Specificity , Thrombosis/etiology
11.
Acta Neurochir Suppl ; 87: 49-52, 2003.
Article in English | MEDLINE | ID: mdl-14518523

ABSTRACT

The authors present a case of diffuse axonal injury (DAI) treated by cervical spinal cord stimulation (C-SCS) for gait disturbance. The patient had right hemiparesis of moderate degree, mild ataxia, ideational apraxia and gait disturbance, when admitted to our hospital for rehabilitation. He could not walk by himself, nevertheless neurorehabilitation was done for four months. Xenon-CT was examined by C-SCS loading and the changes of regional cerebral blood flow were significantly increased in both hemispheres, especially in the thalamus. C-SCS was performed continuously on condition of 25 Hz, 200 microsec and 0.5 V, daily for a month. Neurological deficits, especially gait disturbance due to ideational apraxia, were gradually improved after initiation of C-SCS, and the patient could walk by himself. We speculate that C-SCS played a role in triggering improvement of gait disturbance at the chronic stage in our case, and SCS may be helpful for neurorehabilitation of focal symptoms after DAI.


Subject(s)
Diffuse Axonal Injury/complications , Diffuse Axonal Injury/therapy , Electric Stimulation Therapy/methods , Gait Disorders, Neurologic/etiology , Gait Disorders, Neurologic/therapy , Adult , Diffuse Axonal Injury/diagnosis , Gait Disorders, Neurologic/diagnosis , Humans , Male , Spinal Cord , Treatment Outcome
12.
Chem Pharm Bull (Tokyo) ; 49(11): 1479-81, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11724244

ABSTRACT

In the course of our research for biologically active constituents from coniferous plants, a chromone derivative (1) and an abietane derivative (2) were isolated along with several diterpenes from Chamaecyparis pisifera. Structures of the new compounds were determined to be 5,7-dihydroxy-2-(1-acetyl-2-methoxycarbonylethyl)-chromone and rel-(8R,10R,20S)-8,10,20-trihydroxy-9(10-->20)-abeo-abieta-9,13-dien-12-one by means of spectral methods including two-dimensional NMR experiments. Some of these abietane-type compounds isolated from this plants showed antibacterial activitv against the gram-positive bacteria Staphylococcus aureus and Bacillus subtilis.


Subject(s)
Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Chamaecyparis/chemistry , Diterpenes/chemistry , Gram-Positive Bacteria/drug effects , Anti-Bacterial Agents/isolation & purification , Diterpenes/isolation & purification , Diterpenes/pharmacology , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Plant Leaves/chemistry
13.
Anticancer Res ; 21(4A): 2265-72, 2001.
Article in English | MEDLINE | ID: mdl-11724281

ABSTRACT

The in vivo gene delivery of E. coli cytosine deaminase (cd) cDNA and systemic 5-fluorocytosine (5-FC) administration have been studied extensively because of their clinical relevance to cancer gene therapy. This approach has the potent advantage of a stronger bystander effect compared to the previous thymidine kinase suicide gene system of the herpes simplex virus. However, 5-fluorouracil (5-FU), an active metabolite in cd with 5-FC therapy, is not always effective for every type of tumor since the enzymes responsible for further drug metabolism vary significantly in each tissue. In this study, we aimed to increase the sensitivity of 5-FU by transduction of thymidine phosphorylase (dThdPase) cDNA into brain tumor cells. After retroviral transfer of the cDNA, we obtained 9L murine gliosarcoma cells showing stable expression of the target enzyme (9L-dThdPase). The growth of the cells was identical to wild type (9L-WT) or control-vector transfected (9L-Neo) cells in vitro. Sensitivity to 5-FU was increased in 9L-dThdPase cells. After the adenoviral delivery of cytosine deaminase gene into these cells, 9L-dThdPase cells also demonstrated an increased sensitivity to 5-FC. Moreover, we showed that transduction of dThdPase cDNA prolongs the survival of animals bearing intracerebral tumors after experimental in vivo cytosine deaminase gene therapy. These results suggest that transduction of thymidine phosphorylase may be a beneficial approach to increasing the efficacy of cd/5-FC suicide gene therapy in certain types of tumor.


Subject(s)
Antimetabolites, Antineoplastic/pharmacology , Brain Neoplasms/therapy , DNA, Complementary/genetics , Flucytosine/pharmacology , Genetic Therapy/methods , Gliosarcoma/therapy , Nucleoside Deaminases/genetics , Thymidine Phosphorylase/genetics , Adenoviridae/genetics , Animals , Antimetabolites, Antineoplastic/pharmacokinetics , Brain Neoplasms/enzymology , Brain Neoplasms/genetics , Cytosine Deaminase , DNA, Complementary/administration & dosage , Flucytosine/pharmacokinetics , Fluorouracil/pharmacokinetics , Fluorouracil/pharmacology , Genetic Vectors/genetics , Gliosarcoma/enzymology , Gliosarcoma/genetics , Male , Nucleoside Deaminases/metabolism , Rats , Rats, Inbred F344 , Thymidine Kinase/genetics , Thymidine Kinase/metabolism , Thymidine Phosphorylase/biosynthesis , Thymidine Phosphorylase/metabolism , Transduction, Genetic
14.
Health Policy ; 58(3): 231-42, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11641001

ABSTRACT

BACKGROUND: Although several studies have reported the effects of free medical care on compliance in patients with hypertension, no study has reported the effects of an economic incentive, such as subsidized medical costs, on compliance with medication protocol, in patients with hypertension. The unique characteristics of the Japanese health insurance system provide for a 10% decrease in the subsidy for medication immediately on retirement (approximately 60 years of age) for insured patients, and a 100% subsidy for insured patients who are 70 years of age or older. We examined the association between level of health insurance coverage and follow-up rate of medical treatment among Japanese patients with hypertension. METHODS: The subjects, from throughout Japan, were patients with hypertension (n=1236). The study was conducted in 1991. The odds of completing a 1-year treatment in relation to the rate of health insurance reimbursement were calculated using multiple logistic regression analysis. RESULTS: We found the following. (1) Compared with the base group, the odds of completing a 1-year treatment increased to 2.62 or 2.51 in the group whose reimbursement rate was 100%. (2) Compared with the base group, the odds of completing a 1-year treatment was no larger than 1 in the group whose reimbursement rate had been 100% for more than 6 years ('76-'). (3) Compared with the base level, the odds of completing a 1-year treatment increased to 1-1.81 in the group whose liability decreased to 80%. CONCLUSION: Although the results imply that even a small economic incentive might be effective in securing a patient's compliance with anti-hypertensive medical treatment, the effect appear limited in both duration and magnitude.


Subject(s)
Antihypertensive Agents/economics , Antihypertensive Agents/therapeutic use , Hypertension/drug therapy , Patient Compliance , Reimbursement, Incentive , Aged , Drug Costs , Female , Health Services Research , Humans , Hypertension/economics , Japan , Logistic Models , Male , Middle Aged , National Health Programs
15.
Int J Oncol ; 19(3): 525-31, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11494031

ABSTRACT

Simvastatin is one of the competitive inhibitors of HMG-CoA reductase. During clinical trials, it has shown the ability to lower serum cholesterol. We investigated the effect of simvastatin on the growth of malignant gliomas in vitro, semi-in vivo, and in vivo. An in-vitro MTT assay revealed that human malignant glioma cell lines: U-251MG, U-373MG, and U-87MG, and rat malignant glioma cell line C6 were well inhibited in growth in a dose-dependent fashion. An anchorage-independent growth assay showed that the number of colonies (more than 100 microM in size) of human (U-373MG) and rat malignant gliomas (C6) was markedly reduced in a dose-dependent fashion. A flow cytometry analysis revealed that simvastatin treatment led U-251MG cells to accumulate in sub G0-G1. Immunostaining by TUNEL method showed that most glioma cells treated by 10 microM simvastatin had nuclear immunostaining, suggesting apoptotic changes of the treated cells. The human umbilical vein endothelial cells and human lung fibroblasts were inhibited in growth by no more than 20% of controls even with a high dose (10 microM) of simvastatin. In the semi-in vivo model, using newborn rat brain slice cultures, the rhodamine-labeled glioma cells were abolished after 7 days of local simvastatin treatment with fibrin glue probably suggesting that simvastatin led the cells to apoptosis. In rat models using subcutaneously inoculated C6, the local application of simvastatin combined with fibrin glue (spray method) was quite effective in inhibiting the growth of the tumor. These data suggest that simvastatin may be a novel anti-glioma drug, and the local application of simvastatin combined with fibrin glue (by spray method) may be a crucial new clinical strategy against glioma growth.


Subject(s)
Enzyme Inhibitors/therapeutic use , Fibrin Tissue Adhesive/therapeutic use , Glioma/drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Simvastatin/pharmacology , Tissue Adhesives/therapeutic use , Tumor Cells, Cultured/drug effects , Animals , Cell Adhesion/drug effects , Cell Division/drug effects , Dose-Response Relationship, Drug , Drug Therapy, Combination , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Enzyme Inhibitors/pharmacology , Fibrin Tissue Adhesive/administration & dosage , Fibroblasts/drug effects , Fibroblasts/metabolism , Flow Cytometry , Glioma/enzymology , Glioma/pathology , Humans , Hydroxymethylglutaryl CoA Reductases/metabolism , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , In Situ Nick-End Labeling , Lung/drug effects , Lung/metabolism , Rats , Rats, Wistar , Rhodamines , Tissue Adhesives/administration & dosage , Tumor Cells, Cultured/enzymology
16.
Carcinogenesis ; 22(1): 193-8, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11159759

ABSTRACT

The modifying effects of dietary administration of the citrus limonoids obacunone and limonin on azoxymethane (AOM)-induced colon tumorigenesis were investigated in two experiments in male F344 rats. In a pilot study, we examined the modifying effects of obacunone and limonin on AOM-induced (20 mg/kg body wt, once a week for 2 weeks) formation of aberrant crypt foci (ACF). Dietary feeding of both compounds at dose levels of 200 and 500 p.p.m. during AOM exposure for 4 weeks ('initiation' feeding) or after AOM treatment for 4 weeks ('post-initiation' feeding) significantly inhibited ACF formation (55-65% reduction by 'initiation' feeding, P < 0.001; 28-42% reduction by 'post-initiation' feeding, P < 0.05-0.002). In a long-term study designed to confirm the protective effects of obacunone and limonin on ACF development, one group was treated with AOM alone and another four groups received the carcinogen treatment plus diets containing 500 p.p.m. test compounds for 3 weeks (initiation phase) or 29 weeks (post-initiation phase). Two groups were treated with obacunone or limonin alone (500 p.p.m. in diet) and one group was maintained on the basal diet. At the termination of the study, dietary exposure to obacunone or limonin during the initiation phase was found to have significantly reduced the incidence of colonic adenocarcinoma (72 versus 25 or 6%, P = 0.004 or 0.00003). Obacunone or limonin feeding during the post-initiation phase also reduced the frequency of colonic adenocarcinoma (72 versus 13%, P = 0.0002). Our results suggest that the citrus limonoids obacunone and limonin might be useful for the prevention of human colon cancers.


Subject(s)
Anticarcinogenic Agents/pharmacology , Benzopyrans/pharmacology , Benzoxepins/pharmacology , Colonic Neoplasms/prevention & control , Drugs, Chinese Herbal/pharmacology , Limonins , Precancerous Conditions/prevention & control , Triterpenes/pharmacology , Animals , Azoxymethane/antagonists & inhibitors , Azoxymethane/toxicity , Carcinogens/antagonists & inhibitors , Carcinogens/toxicity , Colonic Neoplasms/chemically induced , Diet , Dose-Response Relationship, Drug , Eating/drug effects , Male , Pilot Projects , Precancerous Conditions/chemically induced , Rats , Rats, Inbred F344
18.
Cancer Res ; 60(14): 3713-6, 2000 Jul 15.
Article in English | MEDLINE | ID: mdl-10919638

ABSTRACT

The modifying effects of the organoselenium 1,4-phenylenebis(methylene)selenocyanate (p-XSC) and the Citrus antioxidant auraptene as dietary supplements on experimental pulmonary metastasis of B16BL6 murine melanoma cells were investigated in an i.v. injection model in mice. Seven groups of male C57BL/6 mice were fed a basal diet (control group) or the basal diet supplemented with p-XSC (4, 8, or 15 mg/kg) or auraptene (250, 500, or 1000 mg/kg). All mice were fed their respective diet for 2 weeks before and after i.v. injection of 1 x 10(5) viable melanoma cells. At termination of the study, the incidence of lung metastatic tumors was determined. Cross-sectional areas and tumor volumes were analyzed morphometrically. In addition, apoptotic indices of lung metastatic tumors of all groups were counted. The incidences of lung metastasis in mice fed the diet mixed with 8 or 15 mg p-XSC/kg were significantly smaller than that in mice fed the basal diet. The mean numbers of metastatic lung tumors were significantly lower in mice fed p-XSC (4, 8, and 15 mg/kg) and auraptene (500 and 1000 mg/kg) than in controls. Cross-sectional areas and volumes of the tumors were also significantly decreased in mice given p-XSC (8 or 15 mg/kg) and auraptene (500 mg/kg). Apoptotic indices in mice fed the diets mixed with p-XSC (4, 8, or 15 mg/kg) and auraptene (500 and 1000 mg/kg) were significantly greater than those in the control group. These results indicate that in mice, diet supplementation with p-XSC and auraptene reduces pulmonary metastasis of B16BL6 melanoma cells and inhibits the growth of these metastatic tumors in lung, in part, by inducing apoptosis. We suggest that these agents, especially p-XSC, may be valuable in preventing metastatic diseases in future studies in the clinic.


Subject(s)
Anticarcinogenic Agents/pharmacology , Coumarins/pharmacology , Dietary Supplements , Lung Neoplasms/drug therapy , Lung Neoplasms/secondary , Melanoma, Experimental/drug therapy , Melanoma, Experimental/pathology , Organoselenium Compounds/pharmacology , Animals , Apoptosis , Dose-Response Relationship, Drug , Liver Neoplasms, Experimental/drug therapy , Liver Neoplasms, Experimental/pathology , Lung Neoplasms/pathology , Lung Neoplasms/prevention & control , Male , Mice , Mice, Inbred C57BL , Neoplasm Transplantation , Neoplasms, Experimental/drug therapy , Neoplasms, Experimental/pathology , Neoplasms, Experimental/prevention & control , Tumor Cells, Cultured
19.
Oncol Rep ; 7(3): 501-8, 2000.
Article in English | MEDLINE | ID: mdl-10767359

ABSTRACT

Patients with long-standing ulcerative colitis (UC) have an increased risk for developing colorectal cancer (CRC) compared to the general population. For investigation of the mechanisms and prevention of UC and UC-related CRC, establishment of a promising animal model for such disease is important. 1-hydroxyanthraquinone (1-HAQ) present in certain medicinal plants such as Rubia tinctorum L. is a genotoxic and rodent colon carcinogen. Long-term feeding of 1-HAQ induced hyper-cell proliferation in rat colonic crypts with ulcerative changes, crypt abscess, severe inflammation and erosion before the occurrence of tumors, which are similar to those found in human UC. In addition, 1-HAQ has a synergistic effect with methylazoxymethaol (MAM) acetate on colon carcinogenesis. The polymerase chain reaction-single strand conformation polymorphism analysis revealed no mutations in Ki-ras and p53 in colonic neoplasms induced by MAM acetate + 1-HAQ, MAM acetate alone or 1-HAQ alone. Also, no mutations of APC were found in these tumors. These findings are similar to those found in human ulcerative colitis-associated colon cancer in contrast with sporadic colon cancers. A previous study revealed that induced colonic tumors had beta-catenin mutation with high frequency, suggesting tumor development by activation of the beta-catenin-Tcf signaling pathway. Increased expression in TNF-alpha and IL-1alpha was found in these induced colonic neoplasms, and the expression was more remarkable in colonic mucosa of rats exposed to MAM acetate + 1-HAQ, MAM acetate or 1-HAQ when compared with that in untreated rats. Thus, these cytokines may act as growth factors in rat colon carcinogenesis by MAM acetate and 1-HAQ and the synergistic effect of 1-HAQ with MAM acetate might be related to the biological effects of the cytokines expressed in the inflammatory conditions induced by 1-HAQ.


Subject(s)
Anthraquinones/toxicity , Carcinogens/toxicity , Colitis, Ulcerative/complications , Colonic Neoplasms/chemically induced , Colonic Neoplasms/etiology , Methylazoxymethanol Acetate/toxicity , Animals , Colon/drug effects , Colon/pathology , Humans , Intestinal Mucosa/drug effects , Intestinal Mucosa/pathology , Rats
20.
Cell Prolif ; 33(1): 29-38, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10741642

ABSTRACT

Exogenous cyclic AMP has been thought to be a chemical without marked pharmacological effect until now, as it is not capable of penetrating the cell membrane in most eucaryotic cells. The present study obtained results consistent with those of most previous studies, showing that exogenous cyclic AMP itself did not interfere with the cell cycle even at the high dose of 100 microM. However, it was found that K252a, a potent inhibitor of protein kinases including protein kinase C, induced DNA re-replication, i.e. DNA synthesis at a elevated DNA ploidy in cells that had not undergone cytokinesis (leading to polyploidization), and that exogenous cyclic AMP markedly potentiated the K252a-induced polyploidization at a very low dose similar to the effective dose of membrane-permeable cyclic AMP analogue dibutyryl cyclic AMP. These findings suggested that the cell membrane changed during the formation of polyploid cells. This supposition was confirmed by scanning electron microscopy to observe structural changes and by determination of cellular attachment to investigate functional changes.


Subject(s)
Carbazoles/pharmacology , Cell Membrane/drug effects , Cell Membrane/ultrastructure , Enzyme Inhibitors/pharmacology , Polyploidy , Protein Kinase C/antagonists & inhibitors , Animals , Bucladesine/pharmacology , Cell Adhesion/drug effects , Cell Division/drug effects , Cell Line , Cell Membrane/metabolism , Cyclic AMP/pharmacology , DNA/metabolism , Indole Alkaloids , Mice , Microscopy, Electron, Scanning
SELECTION OF CITATIONS
SEARCH DETAIL